CTChristian Teglgaard

Christian Teglgaard

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Christian Teglgaard has a total of 15 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Cardiotoxicity in patients with acute myeloid leukaemia following anthracycline‐containing chemotherapy: A population‐based matched cohort study

    by Rikke Hedegaard Jensen, Christian Teglgaard, Jonas Faartoft Jensen, Joachim Baech, Claus Werenberg Marcher, Anne Stidsholt Roug, Andreas Due Ørskov, Claudia Schöllkopf, Daniel Tuyet Kristensen, Rasmus Froberg Brøndum, et al.

    Summary: Anthracycline‐containing chemotherapy is associated with cardiovascular diseases (CVDs). While knowledge regarding the extent of cardiotoxicity in adult patients with acute myeloid leukaemia (AML) is sparse, anthracyclines remain a key component in the treatment. To address this, 1379 adult AML patients treated with anthracycline‐containing chemotherapy between 2000 and 2020 were matched to 6895 comparators from the Danish background population and followed for a median of 11.8 and 12.8 years respectively. The risk of congestive heart failure (CHF) was higher in AML patients compared to the comparators throughout the entire follow‐up period with adjusted hazard ratios (HRs) ranging from 15.0 (95% CI: 7.02–32.1) after 3 months to 2.68 (95% CI: 1.67–4.30) after 15 years. The risk of non‐CHF CVD was initially higher in AML patients (adjusted HR: 9.16 [95% CI: 6.61–12.7] after 3 months) but converged to that of the comparators after approximately 10 years. Among AML patients, increasing age and male sex were identified as risk factors of CHF and non‐CHF CVD. In summary, AML patients treated with anthracycline‐containing chemotherapy had an elevated risk of CVD, particularly during the first years after treatment initiation. Increased focus on early detection and cardioprotective strategies may help mitigate the harmful effects of anthracyclines in the future.


  • Open Access

    Spatial distribution of acute myeloid leukaemia in Denmark

    by Rikke Hedegaard Jensen, Christian Teglgaard, Lars Hernández Nielsen, Lise Dueholm Bertelsen, Heidi Søgaard Christensen, Martin Bøgsted, Marianne Tang Severinsen

    Although various occupational and environmental exposures are suspected risk factors for acute myeloid leukaemia (AML), the aetiology of AML is largely unknown. We present an analysis of the spatial distribution of AML in Denmark on an unprecedented, detailed scale. Such investigations have the potential to uncover geographical areas of increased risk, which may in turn be tied to environmental or occupational exposures. Individuals diagnosed with AML during 2000–2020 were obtained from the Danish National Acute Leukaemia Registry and assigned to a parish based on their residence six months prior to diagnosis. The incidence rate ratio (IRR) by parish was calculated as the ratio between the age- and sex-standardised incidence rate and the national incidence rate. The IRRs were smoothed using a spatial Poisson distributed generalised linear mixed model with a conditional autoregressive correlation structure. Parishes with a smoothed IRR > 1.10 with a posterior probability > 75% were considered to have an increased risk of AML. The study included 5,177 AML cases. The spatial model showed a homogeneous distribution of AML in Denmark with no parishes having an increased risk. The study indicates that the risk of developing AML in Denmark is not affected by place of residence, suggesting that if an unknown environmental or occupational risk factor is present, it does not seem to be associated with specific areas.

  • Open Access

    Detailed mapping of mesothelioma cases in Denmark to identify areas with elevated risk: a nationwide population-based study

    by Heidi Søgaard Christensen, Rikke Hedegaard Jensen, Lars Hernández Nielsen, Lise Dueholm Bertelsen, Christian Teglgaard, Jakob Bønløkke, Marianne Tang Severinsen, Martin Bøgsted

    Objectives: Previous studies mapping pleural mesothelioma in Denmark have found that the risk varies between Danish regions. However, evaluating disease risk for such relatively large geographical units ignores any heterogeneity within the unit and can thus diminish more local spikes in risk, missing smaller areas of excess risk. In this study, we examined the distribution of pleural mesothelioma in Denmark on an unprecedented detailed scale, mapping cases to each of the Danish parishes. Methods: We identified individuals diagnosed with pleural mesothelioma between 1990 and 2021 in the Danish Cancer Registry. Considering age- and sex-standardised incidence rate ratios, we used a conditional autoregressive random effects model to smooth incidence rate ratios across parishes. Parishes with a smoothed parish-to-national incidence rate ratio higher than 1.25 or 2.0 with a posterior probability of more than 95% were flagged as parishes with an excess risk of pleural mesothelioma. Results: We identified 3105 incident cases of pleural mesothelioma in the study period. A total of 73 and 14 parishes were flagged with incidence rate ratios significantly above 1.25 and 2.0, respectively. The flagged parishes had smoothed incidence rate ratios ranging from 1.80 to 4.65. Conclusions: We provided a detailed mapping of pleural mesothelioma cases in Denmark and found five distinct areas, each covering several parishes, with a significantly elevated risk. All these areas were in the proximity of previous asbestos-using industries.